The ischemia-modified albumin in relation to pacemaker and defibrillator implantation

Pacing and Clinical Electrophysiology : PACE
Eftihia SbarouniDimitrios Th Kremastinos

Abstract

Ischemia-modified albumin (IMA) is considered a marker of myocardial ischemia whereas cardiac enzymes are released when cardiac necrosis occurs. It has previously been shown that permanent pacemaker-defibrillator insertion is associated with myocardial injury expressed as cardiac enzyme rise. We assessed whether pacemaker-defibrillator implantation also induces changes in IMA plasma levels and whether, therefore, myocardial ischemia precedes necrosis. We studied 64 consecutive patients undergoing pacemaker or defibrillator implantation; 43 were men and 21 women and their age was 70 +/- 11 years (range 23-84 years). Blood samples were collected at baseline, six hours and 48 hours following the procedure. IMA measured by the albumin cobalt binding test (ACB, Integra 800 analyzer), as well as creatine kinase (CK), the MB isoenzyme of creatine kinase (CK-MB) and cardiac troponin I (Tn-I) were evaluated. Data analysis showed that compared to baseline measurements, IMA increased at six hours (P = 0.015) and at 48 hours (P = 0.003)[97.6 +/- 10.2 vs 101.4 +/- 10.7 vs 102.1 +/- 9.2 U/mL at baseline, six hours and 48 hours, respectively]; similarly, CK increased at six hours (P = 0.0001) and remained high at 48 hours (P = 0.0001) [74.9 +...Continue Reading

References

Mar 12, 1999·The American Journal of Cardiology·J A JoglarR L Page
Aug 10, 1999·Journal of the American College of Cardiology·T M HurstB Waldecker
Mar 26, 2003·Clinical Chemistry·David A MorrowElliott M Antman
Feb 5, 2004·The American Journal of Cardiology·Debashis RoyJuan Carlos Kaski
Jul 13, 2004·The American Journal of Cardiology·Debashis RoyJuan Carlos Kaski
Oct 6, 2004·Pacing and Clinical Electrophysiology : PACE·Christopher J BoosRanjit More
Dec 20, 2005·Pacing and Clinical Electrophysiology : PACE·Nikolaos I NikolaouDimitrios L Tsigas
Dec 19, 2006·Journal of the American College of Cardiology·Eftihia SbarouniDimitrios Th Kremastinos
Jan 11, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Eftihia SbarouniDimitrios Th Kremastinos

❮ Previous
Next ❯

Citations

Nov 19, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Eftihia SbarouniVassilis Voudris
Mar 14, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Eftihia SbarouniVassilis Voudris
Dec 10, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Eftihia SbarouniVassilis Voudris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Journal of Clinical Laboratory Analysis
Eftihia SbarouniVassilis Voudris
Cerebrovascular Diseases
Halim AbboudPierre Amarenco
© 2021 Meta ULC. All rights reserved